219 related articles for article (PubMed ID: 7528447)
21. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
Cuthbert RJ; Craig JI; Ludlam CA
Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956
[No Abstract] [Full Text] [Related]
22. Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma--a randomised pilot study.
Bergmann L; Karakas T; Knuth A; Lautenschläger G; Mitrou PS; Hoelzer D
Eur J Cancer; 1995 Dec; 31A(13-14):2164-8. PubMed ID: 8652236
[TBL] [Abstract][Full Text] [Related]
23. Cyclophosphamide, epirubicin, vincristine, prednisone, bleomycin, etoposide (CEOP-BE) therapy for intermediate- and high-grade non-Hodgkin's lymphomas.
Mugitani A; Tatsumi Y; Tanaka K; Yasui Y; Inoue T
Anticancer Res; 1999; 19(4C):3393-7. PubMed ID: 10629625
[TBL] [Abstract][Full Text] [Related]
24. Combination of chemotherapy and antiviral therapy for Epstein-Barr virus-associated non-Hodgkin's lymphoma of high grade malignancy in cases of HIV infection.
Brockmeyer NH; Pohl G; Mertins L
Eur J Med Res; 1997 Mar; 2(3):133-5. PubMed ID: 9113504
[TBL] [Abstract][Full Text] [Related]
25. [Results of treating patients with highly malignant non-Hodgkin's lymphomas; comparison of treatment efficacy with CHOP and CBVPM-AVBP].
Urasiński I; Zdziarska B; Wichert K; Zuk E
Pol Merkur Lekarski; 1998 Mar; 4(21):137-9. PubMed ID: 9640064
[TBL] [Abstract][Full Text] [Related]
26. Clinical trials referral resource. AIDS-related non-Hodgkin's lymphomas.
Cheson BD; Feigal EG
Oncology (Williston Park); 1993 Apr; 7(4):37-8. PubMed ID: 7683481
[No Abstract] [Full Text] [Related]
27. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
28. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
29. [Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
Hattori M; Motomura S; Tomita N; Taguchi J; Tanabe J; Sakai R; Fujisawa S; Fukawa H; Kanamori H; Mouri H; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1996 Feb; 37(2):101-8. PubMed ID: 8852026
[TBL] [Abstract][Full Text] [Related]
30. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
Doorduijn JK; van der Holt B; van Imhoff GW; van der Hem KG; Kramer MH; van Oers MH; Ossenkoppele GJ; Schaafsma MR; Verdonck LF; Verhoef GE; Steijaert MM; Buijt I; Uyl-de Groot CA; van Agthoven M; Mulder AH; Sonneveld P
J Clin Oncol; 2003 Aug; 21(16):3041-50. PubMed ID: 12915593
[TBL] [Abstract][Full Text] [Related]
31. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
Armitage JO
N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
[No Abstract] [Full Text] [Related]
32. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
[TBL] [Abstract][Full Text] [Related]
33. [Massive bilateral non-Hodgkin's lymphoma of the adrenal glands].
Arai N; Hara A; Umeda M; Shirai T
Rinsho Ketsueki; 1990 Sep; 31(9):1576-80. PubMed ID: 1701010
[TBL] [Abstract][Full Text] [Related]
34. [Lactic acidosis in non-Hodgkin's lymphoma].
Navigante AH; Chacón RD
Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
[No Abstract] [Full Text] [Related]
35. [Treatment by the CHOP protocol in malignant non-Hodgkin lymphomas with high malignancy].
Gociu M; Leahu S; Stoica I; Iofciulescu A; Berceanu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):47-51. PubMed ID: 2899347
[No Abstract] [Full Text] [Related]
36. COP-BLAM regimen combined with granulocyte colony-stimulating factor and high-grade non-Hodgkin's lymphoma.
Niitsu N; Umeda M
Eur J Haematol; 1995 Aug; 55(2):88-92. PubMed ID: 7543059
[TBL] [Abstract][Full Text] [Related]
37. [Studies of patients with non-Hodgkin's lymphoma unresponsive to C-MOPP].
Shirakawa S; Shimizu K; Shinkai K; Kojima H; Maruyama F; Sobue R; Ito N; Imura H; Matsui T; Ino T
Rinsho Ketsueki; 1988 Jul; 29(7):1025-30. PubMed ID: 3184470
[No Abstract] [Full Text] [Related]
38. [New therapy of patients with malignant lymphoma using G-CSF].
Asano S
Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):924-7. PubMed ID: 7525813
[No Abstract] [Full Text] [Related]
39. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial.
Kaku K; Takahashi M; Moriyama Y; Nakahata T; Masaoka T; Yoshida Y; Shibata A; Kaneko T; Miwa S
Leuk Lymphoma; 1993 Oct; 11(3-4):229-38. PubMed ID: 8260897
[TBL] [Abstract][Full Text] [Related]
40. [Combined (poly-chemo-radio) therapy of non-Hodgkin's lymphomas].
Baĭsogolov GD; Shakhtarina SV; Polonskaia NIu; Davydov VA
Med Radiol (Mosk); 1989 Aug; 34(8):31-6. PubMed ID: 2770444
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
